arrow
M

Midori Shima

Nara Medical University
H指数:56
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Coagulation potential of concomitant factor VIII administration in people with hemophilia A receiving emicizumab prophylaxis (CAGUYAMA study): a multicenter, open-label, nonrandomized clinical trial

伴有因子Ⅷ同时给药在服用依米西单抗预防的A型血友病患者中的凝血潜能(CAGUYAMA研究):一项多中心、开放标签、非随机临床试验

2026-08-010
PRE
NXTAGE: a phase 1/2 study of NXT007 to assess safety, pharmacokinetics, and efficacy in hemophilia A without inhibitors

NXTAGE:一项关于NXT007的1/2期研究,旨在评估无抑制剂的血友病A患者的安全性、药代动力学和疗效

Blood
IF23.1
2026-02-090
OAAI
AOZORA study: Three-year interim analysis of safety and joint health in pediatric people with hemophilia A receiving emicizumab prophylaxis

AOZORA研究:接受emicizumab预防治疗的血友病A患儿人群安全性与关节健康的三年期中期分析

2025-10-210
OAAI
International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology
2024-09-019
OAAI